Evidence map›Paper›PMID 29020581›Full record

ArticleThe New England journal of medicine2017

CD55 Deficiency and Protein-Losing Enteropathy.

Ahmet Ozen, William A Comrie, Michael J Lenardo

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03950804 (Transcriptome and Metabolic Analyses of CHAPLE Disease Patients With or Without Eculizumab Treatment), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03950804 unknown statusnot on this mapstarted 2018, after this paper: background citation

Transcriptome and Metabolic Analyses of CHAPLE Disease Patients With or Without Eculizumab Treatment

Typeobservational_patient_registrySponsorMarmara UniversityRan2018 to 2020Enrolled60ConditionsCD55 - Cluster of Differentiation Antigen 55 Deficiency, Primary Intestinal Lymphangiectasis, Protein-Losing Enteropathies, Complement Regulatory Factor DefectArmsEculizumab Injection
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. CD55 Is Essential for CD103The American journal of pathology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ahmet OzenMarmara University, Istanbul, Turkey
William A ComrieNational Institute of Allergy and Infectious Diseases, Bethesda, MD
Michael J LenardoNational Institute of Allergy and Infectious Diseases, Bethesda, MD

Funding

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory DisordersZIAAI000769 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN · 2009 to 2024
$16.7M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fontan ProcedureProtein-Losing EnteropathiesHumans

Identifiers

PMID29020581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.